<DOC>
	<DOCNO>NCT02364648</DOCNO>
	<brief_summary>The purpose study examine effect mitochondrion derive oxidative stress vascular function patient moderate severe Chronic Kidney Disease .</brief_summary>
	<brief_title>Mitochondrial Oxidative Stress Vascular Health Chronic Kidney Disease</brief_title>
	<detailed_description>Chronic Kidney Disease ( CKD ) patient increase risk cardiovascular disease . Endothelial dysfunction , characterize reduce bioavailability nitric oxide , independent predictor cardiovascular disease CKD . Increased oxidative stress potential cause endothelial dysfunction patient cohort . This study investigate role mitochondrial derive oxidative stress play CKD relate vascular dysfunction . In controlled , double blind trial , Stage 3-5 CKD patient randomly assign receive 4 week daily dose mitochondrion target antioxidant ( MitoQ ) placebo .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Stage 3 5 Chronic Kidney Disease History cardiovascular disease ; Current pregnancy ; Uncontrolled hypertension ; Uncontrolled hyperlipidemia ; Current hormone replacement therapy ; Current use tobacco product ; Elevated liver enzymes ; Current autoimmune disease ; Daily use antioxidant &gt; 300mg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Endothelium , vascular</keyword>
	<keyword>MitoQ</keyword>
	<keyword>Mitochondria</keyword>
	<keyword>Oxidative Stress</keyword>
	<keyword>Chronic Renal Insufficiency</keyword>
	<keyword>Cardiovascular Disease</keyword>
</DOC>